Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hypoxia × Pancreaticoduodenectomy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 29 Pancreatic Fistula 4 Pancreatic Ductal Adenocarcinoma 2 Jaundice, Obstructive 2 Gastroparesis 2 Bile Duct Neoplasms 2 Recurrence 1 Periampullary Cancer 1 Pancreatitis, Chronic 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Neoplasm Metastasis 1 Metabolic Syndrome 1 Locally Advanced Pancreatic Adenocarcinoma 1 Hypoxia 1 Hemorrhage 1 Fatty Liver 1 Diabetes Mellitus 1 Cholangiocarcinoma 1 Carcinoma, Pancreatic Ductal 1 Adenocarcinoma 1

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 5 pimonidazole 4 fluoroazomycin arabinoside 4 TH 302 4 Radiotherapy 3 Propofol 3 Injections 3 pomalidomide 1 gadobutrol 1 fluoromisonidazole 1 fludarabine 1 alovudine 1 Tirapazamine 1 Thoracotomy 1 Thoracic Surgery, Video-Assisted 1 Temozolomide 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Sevoflurane 1 Saline Solution 1 Pancreaticoduodenectomy 1 Oxygen 1 Nitroglycerin 1 Nimorazole 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Letrozole 1 Ketamine 1 Ipilimumab 1 Hydroxychloroquine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01989000 2018-06-27

MIPA

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Completed

Gastrointestinal

Hypoxia, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡